Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02200770
Recruitment Status : Active, not recruiting
First Posted : July 25, 2014
Last Update Posted : June 12, 2019
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 26, 2018
  Estimated Study Completion Date : October 21, 2022